UAB Medicine is the first in Alabama to advance cardiology services by offering a first-of-its-kind heart stent that gradually dissolves in the body.
UAB now offers the largest cancer precision medicine clinical trial, NCI-MATCH, with customized treatments for patients based on genetics.
UAB has implemented a new application suite to improve clinical trial management, and enhance communication among trial sites and with study participants.
Researchers have found that an interaction between a mutant gene and alpha synuclein in neurons leads to hallmark pathologies seen in Parkinson’s disease, findings that may lead to new mechanisms and targets for neuroprotection.
UAB continues to improve maternal and infant health as the only university to be a member of all three NIH perinatal networks.
Heat illness can be a serious matter, say UAB emergency physicians. Be prepared, and be safe.
A quality-control checkpoint in pre-B cells restricts the range of antibodies produced by mature B cells, and manipulation of the checkpoint could make vaccines more potent.
The iKnife, a revolutionary mass spectrometry method, contributes to precision surgery by allowing accurate identification of cancer margins.
A pilot grant was recently awarded to UAB to investigate a noninvasive method of detecting neuroinflammation in rheumatoid arthritis.
The NIH recently awarded UAB $11.5 million to support studies that will assess treatment of babies born with congenital cytomegalovirus but no symptoms, and frequency of neonatal herpes infections in the United States and Peru.